Coordinated the €16.5M 2G BIOPIC project developing atmospheric-pressure organosolv for bioethanol, and contributed lignin expertise to LigniOx.
COMPAGNIE INDUSTRIELLE DE LA MATIERE VEGETAL CIM V
French SME developing atmospheric-pressure organosolv biorefinery technology to convert agricultural residues into bioethanol, lignin, and bio-based chemicals.
Their core work
CIMV is a French SME that develops and commercializes organosolv biorefinery technology — a process that breaks down non-food plant biomass (like wheat straw) into three high-value fractions: cellulose for second-generation bioethanol, lignin for industrial chemicals, and hemicellulose-derived products. Their core technology operates at atmospheric pressure, which significantly reduces capital costs compared to competing biorefinery approaches. They sit at the intersection of green chemistry and industrial biotechnology, turning agricultural residues into drop-in replacements for petroleum-derived products.
What they specialise in
Led 2G BIOPIC, a large-scale Innovation Action focused on sustainable 2G bioethanol from non-food biomass.
Participated in LigniOx (lignin oxidation for dispersants) and produced lignin fractions in 2G BIOPIC's multiproduct biorefinery.
Contributed to CARBOSURF on fermentative production of glycolipid biosurfactants from biomass-derived feedstocks.
Participated in RENESENG II on waste valorisation systems and produced multiple product streams from agricultural residues in 2G BIOPIC.
How they've shifted over time
CIMV's H2020 activity was concentrated between 2015 and 2018, with all four projects launching in that window. Their early work centered on their flagship organosolv biorefinery technology — 2G bioethanol, lignin extraction, and multiproduct processing of non-food biomass. Later participations (LigniOx, RENESENG II) show a shift toward downstream applications of their biorefinery outputs, particularly lignin-derived products and waste valorization, suggesting a move from core process development toward market diversification of their technology platform.
CIMV appears to have moved from proving their core biorefinery process toward commercializing individual output streams (especially lignin), though no new H2020 projects appeared after 2018 — potential partners should verify their current R&D direction and operational status.
How they like to work
CIMV operates primarily as a technology-providing partner (3 of 4 projects), but demonstrated the capacity to coordinate a major Innovation Action (2G BIOPIC, €16.5M). With 42 unique partners across 13 countries, they build broad European networks rather than relying on a small circle of repeat collaborators. Their mix of large Innovation Actions and a Marie Skłodowska-Curie mobility project suggests flexibility in consortium formats.
CIMV has collaborated with 42 distinct partners across 13 European countries, indicating a well-connected position in the biorefinery and bio-based industries research community. Their network spans both academic institutions (MSCA-RISE participation) and industrial partners (Innovation Actions and BBI projects).
What sets them apart
CIMV's atmospheric-pressure organosolv process is their key differentiator — most competing biorefinery technologies require high-pressure equipment, which drives up costs and limits scalability. As an SME that coordinated a €16.5M demonstration project, they combine deep technical ownership of a proprietary process with proven ability to manage large-scale EU projects. For consortium builders in bio-based industries, they offer both a concrete technology platform and the biomass fractionation expertise to supply lignin, cellulose, or hemicellulose streams to downstream partners.
Highlights from their portfolio
- 2G BIOPICTheir flagship project — €16.57M Innovation Action where CIMV served as coordinator, demonstrating their organosolv bioethanol process at scale under atmospheric conditions.
- LigniOxBBI-funded project focused on turning lignin (a key CIMV biorefinery output) into commercial dispersant products, representing the downstream commercialization of their core technology.
- CARBOSURFShows CIMV's reach beyond bioethanol into fermentation-based biosurfactants, broadening their bio-based chemicals portfolio.